13th November 2020
Big leaps in bone fracture treatment have been possible thanks to technological advancement promoting healing after the first surgical treatment and thus reducing the complication and co-morbidity rates.
From conservative treatment to internal fixation and from non-locking to locking technology: Progressions 50 and 20 years ago demonstrate how technological advancements and related education can bring a substantial improvement in fracture treatment outcome and a significant saving for healthcare systems.
Despite this progress, healing complications still arise and are very expensive. In e.g. on average in Switzerland 10% of distal femoral fractures account for 65% of total related healthcare costs.
Population aging is quickly changing the requirements for medical devices. We need more effective solutions because in the coming years we can expect:
A substantial increase in the number of treatments,
An exponential increase in the number of complications, and
A not sustainable increase of costs allocated to trauma patients.
Biomech Innovations has developed Variable Fixation, the novel locking screw technology based on mechanobiology principles.
Variable Fixation Locking Screws (VFLSTM) provide rigid fixation followed by progressive fracture dynamization, when they matter. Gradually transitioning from one fixation method to the other, they increase the chance to trigger the fracture healing process and promote the formation of larger amount of bone callus.
Implanted with existing surgical techniques and instruments this technology is virtually compatible with all locking technologies and doesn't require any investment in equipment.
With substantial academic and industrial experience Dr. Stefano Brianza (CEO, Founder) and Dr. Ute Wiesemann (Quality and Regulatory) believe in lean and evidence-based product development.
Status and next steps
Biomech Innovations AG is ISO 13485:2016 certified. Their first product, the 5.0 mm Variable Fixation Locking Screw is CE marked. In Q1 2020 we start clinical activity with prestigious academic trauma centres and limited launch exporting in selected European countries.